Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Bokemeyer

Showing results (561-570 of 664) with videos related to

Pageof 67
Sort By:
Genes, Chromosomes & Cancer|June 29, 2006
A novel fusion of the MALT1 gene and the microtubule-associated protein 4 (MAP4) gene occurs in diffuse large B-cell lymphomaEva M Murga Penas, Holli Kawadler, Reiner Siebert, et al.
European Urology|November 3, 2012
Cabazitaxel plus prednisone for metastatic castration-resistant prostate cancer progressing after docetaxel: results from the German compassionate-use programmeAxel Heidenreich, Hans-Jörg Scholz, Sebastian Rogenhofer, et al.
General Hospital Psychiatry|March 19, 2025
Existential distress in advanced cancer: A cohort studyRebecca Philipp, Charlotte Walbaum, Uwe Koch, et al.
Marine Drugs|May 15, 2020
Inspired by Sea Urchins: Warburg Effect Mediated Selectivity of Novel Synthetic Non-Glycoside 1,4-Naphthoquinone-6S-Glucose Conjugates in Prostate CancerSergey A Dyshlovoy, Dmitry N Pelageev, Jessica Hauschild, et al.
British Journal of Cancer|July 7, 2026
Functional and omics-based rationale for the induction of BRCAness by androgen receptor pathway inhibitors to sensitize prostate cancer to PARP inhibition, regardless of HRR statusMohamed E Elsesy, Ayham Moustafa, Su-Jung Oh-Hohenhorst, et al.
Acta Haematologica|April 12, 2017
Autologous Stem Cell Transplantation in Multiple Myeloma in the Era of Novel Drug Induction: A Retrospective Single-Center AnalysisGabriela B Thoennissen, Dennis Görlich, Ulrike Bacher, et al.
Haematologica|March 24, 2018
BET-inhibition by JQ1 promotes proliferation and self-renewal capacity of hematopoietic stem cellsMark Wroblewski, Marina Scheller-Wendorff, Florian Udonta, et al.
European Journal of Cancer (Oxford, England : 1990)|December 26, 2021
Corrigendum to "Conceptual framework for precision cancer medicine in Germany: Consensus statement of the Deutsche Krebshilfe working group 'Molecular Diagnostics and Therapy'" [European Journal of Cancer 135 (2020) 1-7]C Benedikt Westphalen, Carsten Bokemeyer, Reinhard Büttner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 28, 2011
ERG status is unrelated to PSA recurrence in radically operated prostate cancer in the absence of antihormonal therapySarah Minner, Malaika Enodien, Hüseyin Sirma, et al.
JNCI Cancer Spectrum|April 25, 2025
Associations between early tumor shrinkage/depth of response and survival from the ARCAD databaseHideaki Bando, Yuriko Takeda, Toshihiro Misumi, et al.
Pageof 67

Showing results (561-570 of 664) with videos related to

Sort By:
Pageof 67
Genes, Chromosomes & Cancer|June 29, 2006
A novel fusion of the MALT1 gene and the microtubule-associated protein 4 (MAP4) gene occurs in diffuse large B-cell lymphomaEva M Murga Penas, Holli Kawadler, Reiner Siebert, et al.
European Urology|November 3, 2012
Cabazitaxel plus prednisone for metastatic castration-resistant prostate cancer progressing after docetaxel: results from the German compassionate-use programmeAxel Heidenreich, Hans-Jörg Scholz, Sebastian Rogenhofer, et al.
General Hospital Psychiatry|March 19, 2025
Existential distress in advanced cancer: A cohort studyRebecca Philipp, Charlotte Walbaum, Uwe Koch, et al.
Marine Drugs|May 15, 2020
Inspired by Sea Urchins: Warburg Effect Mediated Selectivity of Novel Synthetic Non-Glycoside 1,4-Naphthoquinone-6S-Glucose Conjugates in Prostate CancerSergey A Dyshlovoy, Dmitry N Pelageev, Jessica Hauschild, et al.
British Journal of Cancer|July 7, 2026
Functional and omics-based rationale for the induction of BRCAness by androgen receptor pathway inhibitors to sensitize prostate cancer to PARP inhibition, regardless of HRR statusMohamed E Elsesy, Ayham Moustafa, Su-Jung Oh-Hohenhorst, et al.
Acta Haematologica|April 12, 2017
Autologous Stem Cell Transplantation in Multiple Myeloma in the Era of Novel Drug Induction: A Retrospective Single-Center AnalysisGabriela B Thoennissen, Dennis Görlich, Ulrike Bacher, et al.
Haematologica|March 24, 2018
BET-inhibition by JQ1 promotes proliferation and self-renewal capacity of hematopoietic stem cellsMark Wroblewski, Marina Scheller-Wendorff, Florian Udonta, et al.
European Journal of Cancer (Oxford, England : 1990)|December 26, 2021
Corrigendum to "Conceptual framework for precision cancer medicine in Germany: Consensus statement of the Deutsche Krebshilfe working group 'Molecular Diagnostics and Therapy'" [European Journal of Cancer 135 (2020) 1-7]C Benedikt Westphalen, Carsten Bokemeyer, Reinhard Büttner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 28, 2011
ERG status is unrelated to PSA recurrence in radically operated prostate cancer in the absence of antihormonal therapySarah Minner, Malaika Enodien, Hüseyin Sirma, et al.
JNCI Cancer Spectrum|April 25, 2025
Associations between early tumor shrinkage/depth of response and survival from the ARCAD databaseHideaki Bando, Yuriko Takeda, Toshihiro Misumi, et al.
Pageof 67